Aug 11 • Psychedelic Experiences
Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
Hey everyone, great news from the psychedelic research world! A new Phase 2b study by Beckley Psytech on an intranasal formulation of 5-MeO-DMT (BPL-003) for treatment-resistant depression showed some really positive results.
The study found that a single dose of the drug produced rapid and long-lasting antidepressant effects. Participants' depression scores significantly decreased and stayed low for up to 57 days. The drug was also well-tolerated. This is a huge step forward for psychedelic medicine and could lead to a new treatment option for depression.
You can read the full article here: https://psychedelicalpha.com/news/beckleys-5-meo-dmt-shows-rapid-durable-antidepressant-effects-in-phase-2b-study
6
2 comments
Beckley’s 5-MeO-DMT Shows Rapid, Durable Antidepressant Effects in Phase 2b Study
skool.com/shangriballa
Join our free non-dual community to connect with a global family of seekers. Discover your inner guru and integrate spiritual wisdom into your life.
Leaderboard (30-day)
1
+4
2
+3
3
+3
4
+2
5
+2
Powered by